Liver Center News

Nima Fattahi, MD, an associate research scientist, works in the lab of Matthew McConnell, MD, exploring how alcohol affects liver function and immune pathways. His journey — from a small Kurdish city in Iran to the Yale Liver Center — reflects a lifelong commitment to bridging science, compassion, and community.

Tamar Taddei, MD, professor of medicine (digestive diseases), is investigating whether statins – a common, inexpensive medication – may be used to help treat cirrhosis and slow the progression to decompensated cirrhosis. In a Q&A, Taddei discusses current understanding of how statins function and her motivations and challenges in pursuing this line of research.

New findings suggest GLP-1 receptor agonists like Ozempic reduce alcohol metabolism and its toxic metabolites. But they may also raise blood alcohol levels.

A new collaborative program, the Ugandan Registry of RMDs in HIV (GEMINI), aims to improve the study of HIV and rheumatic and musculoskeletal diseases (RMDs) in Uganda.

In a new study, published in Proceedings of the National Academy of Sciences, Yale School of Medicine researchers showed that excess cholesterol stored in the liver can directly drive fibrosis in the context of metabolic disease.

Recent research found that BMI is not a good predictor of mortality, adding to a growing body of evidence against the health metric. Here's what to measure instead.

In a new study, Yale researchers develop a method that has the potential to cure cystic fibrosis prior to birth. 

The NIH/NIDDK P30 Liver Center grant provides for the annual submission of pilot projects ($40,000 direct costs each) from both Liver Center and non-Liver Center investigators.

Congratulations to the Yale Department of Internal Medicine faculty members who were recently promoted, appointed, or reappointed.